Quarterly report pursuant to Section 13 or 15(d)

Statements of Stockholder's Equity (unaudited)

v3.24.1.1.u2
Statements of Stockholder's Equity (unaudited) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Balance, shares at Dec. 31, 2022   770,115    
Balance, amount at Dec. 31, 2022 $ 6,021,854 $ 77 $ 51,614,965 $ (45,593,188)
Stock-based compensation 131,260 $ 0 131,260 0
Issuance of common stock and warrants, net of issuance costs, shares   85,000    
Issuance of common stock and warrants, net of issuance costs, amount 4,174,985 $ 9 4,174,976 0
Issuance of common stock upon exercise of pre-funded warrants, shares   1,533,123    
Issuance of common stock upon exercise of pre-funded warrants, amount 153 $ 153    
Settlement of fractional shares paid in cash, shares   (81)    
Settlement of fractional shares paid in cash, amount (40)   (40)  
Net loss (2,240,142)     (2,240,142)
Balance, shares at Mar. 31, 2023   2,388,157    
Balance, amount at Mar. 31, 2023 8,088,070 $ 239 55,921,161 (47,833,330)
Balance, shares at Dec. 31, 2023   3,930,840    
Balance, amount at Dec. 31, 2023 6,355,018 $ 393 59,742,503 (53,387,878)
Stock-based compensation 587,234 0 587,234 0
Net loss (3,134,262) $ 0 0 (3,134,262)
Issuance of abeyance shares, shares   2,730,000    
Issuance of abeyance shares, amount 0 $ 273 (273) 0
Balance, shares at Mar. 31, 2024   6,660,840    
Balance, amount at Mar. 31, 2024 $ 3,807,990 $ 666 $ 60,329,464 $ (56,522,140)